SARS-CoV-2 is the virus that causes COVID-19. The name stands for “severe acute respiratory syndrome coronavirus 2,” and it was officially classified on February 11, 2020, the same day the World Health Organization named the disease it causes. Understanding the distinction matters: SARS-CoV-2 is the pathogen itself, while COVID-19 is the illness you experience when infected.
Why It’s Called SARS-CoV-2
The International Committee on Taxonomy of Viruses chose the name because the virus is genetically related to the original SARS coronavirus that caused the 2003 outbreak. Analysis showed SARS-CoV-2 forms a sister group to the original SARS virus on the evolutionary tree, meaning they share a common ancestor but are distinct. The “2” simply distinguishes the newer virus from the older one. Despite the shared name, the two viruses behave quite differently in how they spread and how severe their effects tend to be.
WHO separately named the disease COVID-19 (short for “coronavirus disease 2019”) following guidelines developed to avoid stigmatizing any geographic location, animal, or group of people. So when you hear “SARS-CoV-2,” think of the virus particle itself. When you hear “COVID-19,” think of the cough, fever, and other symptoms it can produce.
What the Virus Looks Like
SARS-CoV-2 is an enveloped virus, meaning it wraps itself in a layer of fat (a lipid membrane) stolen from the cells it infects. Studded across that membrane are spike proteins, the club-shaped projections that give coronaviruses their signature crown-like appearance under a microscope. Each spike is actually a cluster of three identical protein chains twisted together, and these spikes are the primary target for vaccines and many treatments.
Inside the envelope sits the virus’s genetic material: a single strand of RNA about 29,900 genetic letters long. That makes it one of the largest RNA viruses known. This RNA strand carries all the instructions the virus needs to hijack a human cell and make copies of itself. Because it uses RNA rather than DNA, the virus mutates relatively quickly, which is why new variants keep emerging.
How It Gets Into Your Cells
The spike protein is the virus’s key, and the lock is a protein on the surface of your cells called ACE2. ACE2 normally plays a role in regulating blood pressure, but SARS-CoV-2 exploits it as a doorway. The spike protein’s receptor-binding domain latches onto ACE2 with high precision.
Attachment alone isn’t enough. A second protein on your cell surface, called TMPRSS2, acts like a pair of molecular scissors. It cuts the spike protein at specific points, which triggers a shape change that allows the virus’s membrane to fuse directly with your cell membrane. Once fused, the viral RNA spills into the cell and begins commandeering its machinery to produce thousands of new virus copies. This two-step entry process, binding to ACE2 then being cut by TMPRSS2, is why both proteins became major targets for antiviral drug development.
How It Spreads
SARS-CoV-2 spreads primarily through respiratory particles released when an infected person breathes, talks, coughs, sings, or sneezes. These particles exist on a spectrum. Larger droplets (bigger than 5 to 10 micrometers across) tend to fall to surfaces within a short distance. Smaller particles, sometimes called aerosols, can linger in the air for longer periods, especially in poorly ventilated indoor spaces.
The virus can also spread through contact, for instance touching a contaminated surface and then touching your eyes, nose, or mouth, though this is considered a less common route than direct respiratory exposure. Peak transmissibility occurs from just before symptoms appear to a few days after onset, but most infected people can shed virus for up to 10 days.
Incubation Period and Symptoms
How quickly symptoms appear depends partly on which variant you encounter. Early in the pandemic, the average incubation period was about 6.5 days. The Delta variant shortened that to roughly 4.3 days, and Omicron variants shortened it further to a median of 3 to 4 days. This trend toward shorter incubation contributed to faster waves of infection as the virus evolved.
Common symptoms include fever, cough, fatigue, loss of taste or smell, sore throat, and body aches. Severity ranges enormously, from no symptoms at all to life-threatening pneumonia. Age, underlying health conditions, vaccination status, and which variant is involved all influence how sick someone gets.
Variants and Ongoing Evolution
Because SARS-CoV-2 uses RNA as its genetic material and replicates rapidly, mutations accumulate over time. Most mutations are insignificant, but occasionally one changes the spike protein enough to help the virus spread more easily or partially evade immunity from vaccines or prior infection. WHO tracks these changes using a tiered classification system.
As of early 2026, WHO lists JN.1 as a variant of interest, with several variants under monitoring including KP.3.1.1 and BA.3.2. These classifications shift as new lineages rise and fall in global circulation. The naming system uses letters and numbers that reflect the virus’s branching evolutionary tree, with each new sublineage representing a slightly different version of the spike protein or other viral components.
Current Global Status
On May 5, 2023, the WHO declared that COVID-19 no longer qualified as a public health emergency of international concern, ending the highest level of alert after more than three years. This did not mean the virus disappeared. It meant the global health community shifted from emergency response to long-term disease management, similar to how influenza is handled. Countries are no longer required to implement mandatory control measures, though surveillance and vaccination programs continue.
SARS-CoV-2 now circulates as an endemic respiratory virus, causing seasonal waves of infection. Updated vaccines targeting newer variants are released periodically, much like annual flu shots, to keep pace with the virus’s evolution.